MHH Logo


Emmanouilidis N, Müller JA, Jäger MD, Kaaden S, Helfritz FA, Güner Z, Kespohl H, Knitsch W, Knapp WH, Klempnauer J, Scheumann GFW.
Surgery and radio ablation therapy in one step: introducing a 1-week-condensed MHH-prtocol bonding total thyroidectomy with radio-ablation-therapy by recombinant human Thyreotropin
Eur J Endocrinol. 2009 Aug 17


Emmanouilidis N, Guo Z, Dong Y, Newton-West M, Adams AB, Lee ED, Wang J, Pearson TC, Larsen CP, Newell KA.

Immunosuppressive and trafficking properties of donor splenic and bone marrow dendritic cells.

Transplantation. 2006 Feb 15;81(3):455-62


Emmanouilidis N, Larsen CP.<?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />

Induction of chimerism and tolerance using freshly purified or cultured hematopoietic stem cells in nonmyeloablated mice.

Methods Mol Med. 2005;109:459-68.


Shirasugi N, Emmanouilidis N, Pearson TC, Larsen CP.

Ability of donor splenocytes with costimulation blockade to induce mixed hematopoietic chimerism and transplantation tolerance.

Transplant Proc. 2004 Oct;36(8):2423-4.


Schlitt HJ, Barkmann A, Boker KH, Schmidt HH, Emmanouilidis N, Rosenau J, Bahr MJ, Tusch G, Manns MP, Nashan B, Klempnauer J.

Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study.

Lancet. 2001 Feb 24;357(9256):587-91.


Barkmann A, Nashan B, Schmidt HH, Boker KH, Emmanouilidis N, Rosenau J, Bahr MJ, Hoffmann MW, Manns MP, Klempnauer J, Schlitt HJ.

Improvement of acute and chronic renal dysfunction in liver transplant patients after substitution of calcineurin inhibitors by mycophenolate mofetil.

Transplantation. 2000 May 15;69(9):1886-90.